Moreover, since some histologies were underrepresented in our series of cases, we cannot exclude that HMGA1 overexpression may have an impact on the efficacy of trabectedin and patient survival in other sarcoma subtypes, besides leiomyosarcomas. Here, HMGA1 is linked to leiomyosarcoma.